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Severe combined immunodeficiency (SCID) mice have widely been used as hosts for human tumor cell xenograft study.
This animalmodel, however, is labor intensive. As zebrafish is largely emerging as apromisingmodel system for studying
human diseases including cancer, developing efficient immunocompromised strains for tumor xenograft study are also
demanded in zebrafish. Here, we have created the Prkdc-null SCID zebrafish model which provides the stable immune-
deficient background required for xenotransplantation of tumor cell. In this study, the two transcription activator-like
effector nucleases that specifically target the exon3 of the zebrafish Prkdc gene were used to induce a frame shift
mutation, causing a complete knockout of the gene function. The SCID zebrafish showed susceptibility to spontaneous
infection, a well-known phenotype found in the SCIDmutation. Further characterization revealed that the SCID zebrafish
contained no functional T and B lymphocytes which reflected the phenotypes identified in the mice SCID model.
Intraperitoneal injection of human cancer cells into the adult SCID zebrafish clearly showed tumor cell growth forming
into a solid mass. Our present data show the suitability of using the SCID zebrafish strain for xenotransplantation
experiments, and in vivomonitoring of the tumor cell growth in the zebrafish demonstrates use of the animalmodel as a
new platform of tumor xenograft study.
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The DNA-dependent protein kinase catalytic subunit encoded by
Prkdc gene functions in DNA nonhomologous end-joining in
mammalian cells [1,2]. This major DNA double-strand break repair
process also functions during lymphocyte development because of its
fundamental role in V(D)J recombination mediating immunoglobulin
and T-cell receptor gene assembly [3,4]. Consequently, malfunctioning
of the DNA nonhomologous end-joining process in animals causes
severe combined immunodeficiency (SCID), and this has been usefully
applied to animals to develop the tumor study model with
immune-deficient background [5]. In fact, the SCID animal models
are now widely used for xenograft study and have contributed
tremendously to current understanding of various cancers’ initiation
and progression, including prostate cancer [6], ovarian cancer [7],
melanoma [8], non–small cell lung cancer [9], multiple myeloma [10],colon cancer [11], and gastric cancer [12]. Use of immune-deficient
mouse model has been most commonly accepted to study
Neoplasia Vol. 18, No. 8, 2016 Xenotransplantation in Prkdc-Null SCID Zebrafish Jung et al. 469pathophysiological phenotypes of immune disorders. Thus, different
types of genetically engineered mouse strains are now available. These
include the single-gene mutation strains such as nude (nu) strain, Scid
(scid) strain, nonobese (NOD) strain, recombination activating gene
(RAG) strains, and NOD/Scid hybrid strain, etc. [13].
Use of zebrafish in immunological studies has also been introduced
since early 2000 [14], and the zebrafish has proven to be one of the
best vertebrate models for the immunological studies [15,16]. In
these studies, the gene-disruption strategies were effectively used to
define the immunological meanings: Hematopoietic cell transplan-
tation in the zebrafish blood mutant was demonstrated to understand
the blood-forming system [15]. The Rag1 mutant of zebrafish was
generated and characterized to define the lymphocyte population
[16]. In addition, a recent study has revealed that rag2 inactivation of
zebrafish shows a reduced number of functional T and B cells,
allowing tumor cell engraftment [17]. These studies suggest that the
zebrafish has also its potential for the use of the animal as an
immune-deficient model system.
Recently, transcription activator-like effector nuclease (TALEN)
has been used for the complete elimination of gene function in model
or organisms [18,19]. This technique is based on creating the artificial
nuclease that will cut the DNA near a predetermined site and thereby
provides a knockout mutation of the gene of interest. Chromosome
breaks created by the engineered nuclease undergoes nonhomologous
end-joining in the absence of a repair template, introducing the short
DNA insertions or deletions that create the targeted gene knockouts.
In this study, we applied the TALEN which specifically targets and
knocks out the Prkdc gene of zebrafish. Molecular analyses revealed
that the TALEN introduced a frame mutation of the Prkdc gene,
causing a complete knockout of the gene function. Histologic
investigations showed that the transgenic zebrafish contained retarded
growth of hematologic organs and impaired lymphocytes development,
revealing immunodeficiency of the zebrafish. Intraperitoneal injection of
human cancer cell lines into the SCID zebrafish successfully demon-
strated the real-timemonitoring of the tumor cell growth. The aim of our
study was to develop an efficient and laboratory-beneficial zebrafish
model for human tumor xenograft study.Material and Methods
Isolation of Zebrafish PRKDC Gene and Establishment of
TALEN Construct
Human PRKDC (protein kinase, DNA-activated, catalytic polypep-
tide) homolog of zebrafish was searched on the genome database (http://
www.ncbi.nlm.nih.gov) (accession no: mRNA, XM_009303401:
GI688565118; genomic DNA, NC_007118:GI68550835). The
TALEN constructs which target exon 3 of the zebrafish PRKDC were
designed by using a software program (TAL Effector Nucleotide Targeter
2.0: TALEN Targeter) of the Bogdanove laboratory (https://boglab.plp.
iastate.edu/node/add/talen). The TALEN sequences that recognize the
exon 3 of the zebrafish Prkdc gene were 5′-TATGAATTTCT-
TAGGGGCAT-3′ (left arm, RVD sequence: NG NI NG NN NI NI
NG NG NG HD NG NG NI NN NN NN NN HD NI NG) and
5′-TCCTCGGACAGTGGCTGACA-3′ (right arm, RVD sequence:
NGHDHDNGHDNNNNNIHDNINNNGNNNNHDNG
NN NI HD NI) (Figure 1). The nucleotide sequence of the spacer
between two TALEN targets was 5'-TTCTACAGAGAA-3'. Both
TALEN constructs were generated by using TALEN Toolbox kit
(Addgene) and by following the protocol provided by Feng Zhanglaboratory (reference nature protocol). After the sequence verification, the
capped mRNA was produced by in vitro transcription of the plasmid
individually consisting of left or right arm sequences using mMESSAGE
mMACHINE T7 ULTRA kit (Ambion Co.).
Establishment of Prkdc-Null SCID Zebrafish
DNA break at the targeted site was induced by injecting the capped
mRNA into the yolk of AB zebrafish embryos using an MMPI-2
microinjector at single cell stage. Injection mixture was prepared by
reconstituting the mRNAs (final concentration of each mRNA, 30
ng/ml) in Danieu's buffer mixed with 0.03% phenol red. The F1
progenies were obtained by backcrossing the F0 adult zebrafish to AB
wild-type zebrafish. For screening of the germline mutation, the F1
progenies were individually checked by sequence analysis of the
polymerase chain reaction (PCR) products amplified from the
genomic DNA isolated by tail fin clipping. Primer sequences used
to amplify the exon3 sequences were 5′-TTCGCAGGTCTCTGTC-
TACTGAAAA-3′ (forward) and 5′-CTAGTGCAACAAAGATGA-
CATG-3′ (reverse). The identified heterozygote mutant zebrafish
were backcrossed again with the AB zebrafish to produce F2 progenies.
The homozygote Prkdc-null zebrafish were screened from the F3
progenies produced by inbreeding of the F2 heterozygote progenies.
Animal Stocks and Embryo Care
The zebrafish used in this study were propagated and raised in a
standardized aquaria system (Genomic-Design Co., Daejeon, Korea)
(http://zebrafish.co.kr). The system provides continuous water flow,
biofiltration tank, constant temperature maintenance at 28.5°C, UV
sterilization, and 14-hour light and 10-hour dark cycle. The embryoswere
maintained in E3 media for 5 days then transferred to a water tank and
raised. The embryos to be processed for whole mount analyses were
placed in the E3 media with 0.003% phenylthiourea at 24 hpf to inhibit
pigmentation. To provide pathogen-free condition for the
immune-deficient SCID zebrafish, trimethoprim-sulfomethoxazole was
added to water every other week. We strictly followed the Guidelines for
the Welfare and Use of Animals in Cancer Research [19].
Ethics Approval
This study got ethics approval from the ethics committee of
Department of Laboratory Animal Resources, Yonsei Biomedical
Research Institute, Yonsei University College of Medicine (2015-0205).
Statistical Analysis
Statistical analysis was performed by using SPSS 11.0 software.
Wilcoxon rank and Kruskal-Wallis rank sum tests were used for the
validation of statistical significance.
Histology, Immunohistochemistry (IHC), and In Situ
Hybridization (ISH)
Histologic evaluation was done by using 4-μm sections of
paraffin-embedded tissue. Hematoxylin and eosin (H&E) staining was
performed according to standard protocols [16]. IHC and ISH
experiments were carried out as previously described [20,21]. Antibodies
used for IHC were mouse anti-PCNA (ab14370, Abcam), rabbit
anti-Ki67 (sc-15,402, Santa Cruz), rabbit anti-RFP (600-401-379,
Rockland Inc.), mouse anti-zebrafish Prkdc-C (E7F4J7, Abmart), mouse
anti-pancytokeratin (ab961, Abcam), and mouse anti-HLA class1 ABC
(ab70328, Abcam). For ISH experiment, partial cDNA (798 bp)
sequence of zebrafish Rag1 was PCR-amplified by using F-zRag1
(5′-TTCTGAAGATGCTCCCAGAGC-3′) and R-zRag1
Figure 1. Schematic illustration of TALEN-mediated knockout of the zebrafish Prkdc gene. (A) Generation of TALEN constructs. Exon 3 of
the Prkdc gene was targeted with the 12-bp spacer flanked by left and right TALEN arms. (B) Mutagenesis by microinjection of capped
mRNA and strategy for genotyping of the F1 progenies. (C) Sequence confirmation of the mutations with two-nucleotide deletion and
six-nucleotide deletion followed by five-nucleotide insertion (mutation no. 3 and 6, respectively). Both mutations cause a shift of the
translational frame. (D) Western blot analysis for Prkdc. Kidney and spleen were dissected from several zebrafish, and the pooled samples
were processed for the Western blot experiment. C, Prkdc+/−; P, Prkdc−/−. (E) IHC experiment for Prkdc done with the kidney
dissections.
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vector (Invitrogen, Carlsbad, CA). Riboprobes were generated by using
T7 digoxigenin labeling kit (Roche Diagnostics GmbH, Mannheim,
Germany). Hybridization was done at 65°C overnight, and a series of
stringent wash was done at 68°C. The hybridized riboprobes were then
detected by anti-dig antibody binding and visualized by incubating with
NBT/BCIP AP substrate solution (Roche Diagnostics GmbH).
Counterstaining was done with neutral red. Olympus MVX10 was
used for microscopic observation of zebrafish embryos. Photographs from
the slide sections were obtained by using Olympus BX51.
Reverse transcriptase (RT)–PCR and Western Blot Analyses
RT-PCR was performed by using the collected sample of the
dissected kidney and spleen from three adult zebrafish of each group.
RNA sample was extracted by using TRIzol reagent (Invitrogen,
Carlsbad, CA). The cDNA was synthesized by using a Maxima First
Strand cDNA Synthesis Kit (Thermo Scientific Fermentas, K1641,
Glen Burnie, MD). The primer sequences for RT-RCR are shown in
Supplementary Table 1. For Western blot assay, whole cell extracts
were prepared from the pooled samples of the dissected zebrafish
kidney and spleen as described previously [22,23]. Twenty milligrams
of each sample was separated on a 10% SDS–polyacrylamide gel and
transferred onto a PVDF membrane (Amersham, GE Health,
Sweden). The membrane was incubated for overnight at 4°C with
anti–Prkdc-C antibody in a PBS blocking solution (nonfat dry milk).
Horseradish peroxidase–conjugated secondary antibody was used for
postreaction. Labeled proteins were then detected by ECL reagents
and Hyperfilm ECL (Amersham Biosciences).Cytology
For peripheral blood collection, 3-month-old zebrafish were
anesthetized with 0.03% tricaine. Blood was then obtained by
cardiac puncture with micropipette tips coated with heparin and
was smeared onto glass slides for observation. For kidney and spleen,
each organ was dissected under stereomicroscope from 3-month-old
zebrafish and directly smeared onto glass slides by using thick smear
method. The blood, kidney, and spleen smears were processed
through Wright-Giemsa stain as previously described for morpho-
logical analyses and differential cell counts [15]. Immunofluores-
cence (IF) experiments were performed by using the cell smears
with the primary antibodies rabbit anti–CD2-associated protein
(CD2AP) (sc-9137, Santa Cruz Biotechnology Inc.) and mouse
anti-NKP46 (sc-53,599, Santa Cruz Biotechnology Inc.). Cy2-con-
jugated anti-rabbit and cy3-conjugated anti-mouse antibodies were
used as secondary antibodies. Fluorescence images were obtained by
using an Olympus BX51.
Flow Cytometry and Cell Sorting
Peripheral blood was collected by cardiac puncture. The
hematopoietic cells of kidney and spleen were isolated from the
euthanized 3-month-old Prkdc−/+ and Prkdc−/− zebrafish and
processed for flow cytometry. For this experiment, the kidney and
the spleen from each of the three heterozygote and homozygote
mutant zebrafish were dissected under a stereomicroscope and
suspended in an ice-cold 0.9× PBS with 5% FBS by repeated
pipetting using a P1000 pipettor. The cell suspensions were then
passed through a 40-μm Falcon nylon cell strainer (Beckton
Figure 2. Growth phenotypes and microscopic observations of the Prkdc-null SCID zebrafish. (A and B) Growth retardation. The SCID
zebrafish showed a retarded growth in length compared with the age-matched wild-type controls until 3 months. (C) Infectious
manifestation. The immune-deficient SCID zebrafish often succumbed to infection. The emaciated zebrafish died within 7 days, whereas
the “dropsy” zebrafish died within a couple of days. Red arrow shows a magnified view of the dropsy zebrafish fin. (D) Microscopic
findings of the infection and inflammation occurred in the internal organs. The zebrafish with “dropsy” phenotype revealed that the
disseminated infection occurred in the internal organs including brain, intestine, and ovary, suggesting septicemia. The emaciated
zebrafish showed a predominant muscle necrosis with inflammation.
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of 1 μm/ml to exclude dead cells. The suspended cells were then kept
on ice until analysis. Flow cytometry analysis was done based on
propidium iodide exclusion, forward scatter, and side scatter with aFACS flowcytometer (Beckton Dickinson AriaIII). The distinct
fractions of the forward- and side-scattered cells were individually
sorted. The sorted cells were the smeared onto slide glasses and
processed for Wright-Giemsa stain.
Figure 3.Microscopic observation of the hematopoietic organs in the Prkdc-null SCID zebrafish. (A) ISH and H&E images of the thymus.
The ISH experiment for Rag1 in the SCID zebrafish embryo at 4 dpf showed that the mutant zebrafish contained a very rudimentary
thymus development (dotted red circle). H&E staining images at 3 months of age showed that the number of lymphocytes was severely
decreased in the SCID zebrafish (prkdc−/−) compared with the heterozygote (prkdc+/−). (B) Microscopic observation of the zebrafish
kidney. The retroperitoneal hematopoietic kidney tissue appears as dark linear structure. The tissue appeared as thinner with less density
in the SCID zebrafish compared with that of the heterozygote (red arrowhead). H&E staining of the kidney also showed the consistency in
which the kidney of the SCID zebrafish was thinner than that of the heterozygote and contained scanty hematopoietic cells between the
renal tubules. (C) Gross and H&E images of spleen. The spleen of the SCID zebrafish was much smaller than that of the heterozygote.
Compared with the spleen of the heterozygote, small number of lymphocytes was shown to be scattered between splenocytes in the
SCID zebrafish.
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Human cancer cell lines were purchased from American Type Culture
Collection (Manassas, VA) and maintained in the American Type
Culture Collection–recommended growth media at 37°C, 5% CO2.
All of the cancer cells were then transfected with lentiviral particles
to transduce pLemiR-nonsilencing plasmid vector containing the
TurboRED fluorescent protein (tRFP) sequence (Open Biosystem,Huntsville, AL). A week before the xenograft experiment, the SCID
zebrafish were transferred to 35°C aquaria system for adaptation at the
desired temperature. For tumor cell xenograft, the tRFP-expressing tumor
cells were grown until 70% of confluence is reached. The cells were then
resuspended in PBS (2.5 × 106/ml), and 5 × 104 (20 μl) cells were
introduced into the SCID zebrafish by intraperitoneal injection using a
Hamilton syringe. The injected zebrafish were maintained at 35°C
Figure 4. Hematologic findings of the major blood cell lineages. (A) Wright-Giemsa staining with the smeared cells from the peripheral blood,
kidney, and spleen. All images are 1000×viewexcept insets (400×) inmiddle column. Arrowheads are colored as green for lymphocytes, red for
erythroid lineage cells, blue for neutrophils, yellow for thrombocytes, black for monocytes/macrophages, and brown for blasts/precursor cells.
Microscopic observation of these organs revealedmuch decreased number of the lymphocytes in the SCID zebrafish comparedwith the one in
the heterozygote control (detailed counting results are shown in Table 1). The lymphocytes appeared as small cells with a higher nuclear to
cytoplasmic ratio, and themonocytes/macrophages appeared as larger cellswith a lower nuclear to cytoplasmic ratio and cytoplasmic vacuoles.
Direct smear of dissected kidney and spleen also revealed lower lymphocyte fractions in SCID zebrafish. Note the compact cells in the smear of
kidney marrow from control and frequent fat globules (*) in the smear from SCID zebrafish. (B) Flow cytometry. Forward scatter (FSC) and side
scatter (SSC) are proportional to cell size and cellular granularity, respectively. Peripheral blood and single cell suspensions from the dissected
kidney and spleenwere processed for flow cytometry. The flow cytometry demonstrated fourmain cell populations (noted in the box). Note that
lymphocyte fractions are markedly decreased in the SCID zebrafish compared with those of the heterozygote control.
Neoplasia Vol. 18, No. 8, 2016 Xenotransplantation in Prkdc-Null SCID Zebrafish Jung et al. 473environment,monitoring transcutaneous fluorescence every 2 to 3weeks.
The injected zebrafish were sacrificed at 6 weeks and processed for
histologic evaluation.
Results
Generation of Prkdc-Null (SCID) Zebrafish
Human PRKDC homolog of zebrafish is comprised of 86 exons
with a cDNA length of 12,623 bp. Among these, we found that the
exon 3 with 108 bp was ideal for TALEN targeted mutagenesis
(Figure 1A). Thus, two TALEN constructs of left and right arms were
prepared and applied to induce a targeted mutation by injecting the
mRNAs into the yolk of AB zebrafish at one cell stage. By genotyping
eight F1 progenies, two mutations (mutation no. 3 and 6) were
identified at the spacer region of the TALENs. Sequence analysis
showed that the mutation no. 3 and 6 contained AC dinucleotide
deletion and TCTACA deletion followed by CATAT insertion,
respectively, in the exon3 of the Prkdc gene, causing a frameshift
mutation (Figure 1, B and C). We also checked other sites that showsequence similarity to the targeted region at sequence level. Potential
off-target sites were searched using a software program (TAL Effector
Nucleotide Targeter 2.0: Paired Target Finder) of the Bogdanove
laboratory (https://boglab.plp.iastate.edu/node/add/talen). Among
the possible off-targets, the six paired targets that showed a high
rate of similarity were selected and analyzed for the mutation
possibility by sequence analysis. The sequence analysis revealed that
insertion or/and deletion did not occur at any of the off-target sites
among the transgenic zebrafish (data not shown), excluding any
undesired mutations from the genome of the zebrafish.
F2 progenies of the zebrafish were produced by backcrossing the
heterozygote F1 founders to wild-type zebrafish. The adult F2
progenies were then screened for harboring heterozygote mutation
and were in-crossed to produce F3 progenies. Homozygote
Prkdc-null zebrafish were screened within the F3 progenies and
expanded by in-crossing of the homozygotes to secure a stable line of
the SCID zebrafish. We also confirmed the complete loss of the Prkdc
expression by Western blot and IHC experiments (Figure 1, D and E).
For Western blot analysis, the kidney and spleen dissected out from the
Table 1. Differential Cell Counts by Manual Analyses
Peripheral Blood (%) Kidney (%) Spleen (%)
Control SCID Control SCID Control SCID
Number 8 8 6 6 6 6
Myelomonocyte
Neutrophil 20.6 ± 3.8 33.1 ± 4.8 8.5 ± 3.3 (11.7 ± 4.9) 10.6 ± 2.7 (15.3 ± 3.6) 5.0 ± 1.2 (10.2 ± 2.4) 5.7 ± 1.5 (13.2 ± 3.2)
Eosinophil 1.1 ± 0.7 0.5 ± 0.3 0.6 ± 0.7 (0.8 ± 0.9) 1.1 ± 1.1 (1.6 ± 1.5) 1.8 ± 1.3 (3.7 ± 2.6) 2.1 ± 1.1 (4.9 ± 2.4)
Monocyte 14.2 ± 3.1 38.3 ± 7.9 * 5.9 ± 3.9 (8.1 ± 4.3) 10.6 ± 4.3 (15.3 ± 6.9) 4.2 ± 1.6 (8.6 ± 3.3) 8.3 ± 2.6 (19.2 ± 5.5) *
Lymphocyte 63.6 ± 14.3 27.5 ± 9.3 * 33.5 ± 8.3 (46.0 ± 11.1) 19.3 ± 4.2 * (27.8 ± 6.1) 36.7 ± 6.6 (75.1 ± 13.6) 25.5 ± 4.1 * (59.0 ± 9.1)
Precursor (blast) cell 0.5 ± 0.3 0.6 ± 0.5 24.4 ± 4.2 (33.5 ± 5.3) 27.9 ± 4.3 (7.7 ± 3.2) 1.2 ± 0.6 (2.5 ± 1.2) 1.6 ± 0.3 (3.7 ± 0.7)
Erythroid lineage cell NC NC 27.1 ± 7.3 30.5 ± 7.7 51.1 ± 10.2 56.8 ± 10.3
Numbers in parenthesis, % of nonerythroid cells. NC, not counted. Statistical significance was calculated by Kruskal-Wallis rank sum test.
* P b .05 compared with control.
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experiment was done with the paraffin-embedded tissue sections
obtained from the zebrafish kidney. The two experiments showed that
the homozygote zebrafish did not express the Prkdc gene, suggesting
that a complete loss of the gene function occurred in the transgenic
zebrafish. Taken together, our analyses revealed that the homozygote
Prkdc-null SCID zebrafish was successfully generated.
Growth Retardation and Vulnerability to Infection
The SCID zebrafishwere viable and showed slightly retarded growth in
length compared with their age-matched wild-type zebrafish until 3
months of age (Figure 2, A and B). The growth then became comparable
to that of wild-type zebrafish at adult stage. The SCID zebrafish were also
fertile and could be maintained as homozygote for Prkdc mutation but
showed a reduced reproducibility with short egg-laying period that
occurred at 3 to 6 months of age. Both the mutation no. 3 and 6 lines
contained virtually identical morphological phenotype. Themutation no.
6 zebrafish, however, was more prolific than themutation no. 3 zebrafish,
and thus, we carried out further detailed experiments by using the
mutation no. 6 line.
As it has been documented in mouse and rat SCIDmodels, the SCID
mutation is assumed to cause a virtual loss of both T and B lymphocytes.
Susceptibility to spontaneous infection is a well-known phenotype found
in the SCID mutation. In fact, the SCID zebrafish were vulnerable to
spontaneous infection. We often found that the SCID zebrafish showed
the emaciation phenotype caused bymuscle necrosis due to local infection
(Figure 2C). Once the emaciation developed, the infected hosts usually
diedwithin 7 days. The “dropsy” phenotype, a well-known disease caused
by septisemia in teleost fish, was also found. Histologic analysis revealed
that the dropsy zebrafish contained inflammatory infiltration in the
majority of organs including brain, intestine, and ovary (Figure 2D).
Predominant muscle necrosis with the inflammation was found in the
emaciated zebrafish. The SCID zebrafish with “dropsy” usually died
within a couple of days, indicating that the “dropsy” is a more disastrousTable 2. Differential Cell Counts by Flow Cytometry
Blood (%) Kidney (%)
Control SCID Control
Number 12 12 12
Myelomonocyte 2.1 ± 0.2 (36.2 ± 3.7) 2.8 ± 0.3 (50.0 ± 6.7) * 19.8 ± 3.7 (26.3
Lymphocyte 3.0 ± 0.4 (51.7 ± 6.7) 2.1 ± 0.2 (37.5 ± 3.9) * 29.5 ± 5.7 (39.1
Precursor (blast) cell 0.7 ± 0.2 (12.1 ± 3.7) 0.7. ± 0.4 (12.5 ± 7.7) 26.1 ± 4.4 (34.6
Erythroid lineage cell 94.2 ± 3.0 94.4 ± 3.1 24.6 ± 2.5
Numbers in parenthesis, % of nonerythroid cells. Statistical significance was calculated by Kruskal-W
* P b .05 compared with control.infection than the emaciation. The results suggest that the Prkdc-null
SCID zebrafish are vulnerable to infection possibly because of the
reduced immunity.
Analysis of Hematologic Organs
We used Rag1 as an effective marker for the thymus development
(Figure 3A). ISH experiment with 4-day-old embryos showed that the
SCID zebrafish contained dramatically reduced thymus development
compared with the one of our heterozygote control. Histologic
analysis of the thymus in the adult zebrafish revealed that the mutant
also had a significantly decreased number of lymphoid cells. Because
blood production occurs in kidney in adult zebrafish, we investigated
the zebrafish kidney under a stereomicroscope (Figure 3B). The
microscopic observation with the naked kidney clearly showed
morphological differences between the mutant and wild-type
zebrafish. Hematopoietic tissue of the mutant zebrafish kidney
showed much reduced development with the decreased tissue density
compared with that of the heterozygote (Figure 3B, red arrowhead).
Further observations with H&E staining of the kidney tissue section
revealed that the Prkdc-null SCID zebrafish contained a significantly
decreased number of hematopoietic cells (Figure 3B and see the
microscopic view). The spleen, a lymphoid organ, was also
investigated (Figure 3C). We found that the spleen size was
considerably smaller in the SCID zebrafish (1.2 ± 0.2 mm) than in
the heterozygote control (2.0 ± 0.3 mm) (P b .05). Histologic
observation of the spleen showed that the SCID zebrafish contained
a decreased number of lymphoid cells.
Analysis of Hematologic Cells
We also evaluated the hematopoietic cells in the separately prepared
cell smears from peripheral blood, kidney, and spleen (Figure 4A).
Observation of the smears after staining with Wright-Giemsa
suggested that the peripheral blood and the internal organs of the
SCID zebrafish contained significantly decreased number of lymphoidSpleen (%)
SCID Control SCID
12 12 12
± 5.2) 25.9 ± 4.5 (35.3 ± 7.1) 16.1 ± 2.2 (24.7 ± 3.7) 19.1 ± 3.4 (31.8 ± 5.8)
± 6.5) 17.7 ± 3.2 * (24.1 ± 4.5) 32.2 ± 3.3 (49.4 ± 5.7) 22.7 ± 1.7 * (37.8 ± 3.1)
± 6.4) 29.7 ± 6.3 (40.5 ± 7.9) 16.9 ± 7.3 (25.9 ± 9.9) 18.1 ± 7.7 (30.2 ± 10.7)
26.7 ± 2.6 34.8 ± 4.0 40.1 ± 4.4
allis rank sum test.
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ones of the heterozygote control (Figure 4A). Our manual cell
counting indicated that the lymphocyte fraction in the peripheral
blood was present at 63.6% and 27.5% in the control and the SCID
zebrafish, respectively (Table 1). The decreased number of lympho-
cytes in the SCID zebrafish was replaced by monocyte/macrophage
lineage cells. The kidney from SCID zebrafish contained much sparse
marrow cells and more fat globules compared with control, whichFigure 5. IF and RT-PCR analyses for activated lymphocytes. (A) IF
present in the peripheral blood from both SCID and control zebrafish,
cells. DAPI staining was used to detect the blood cells. (B) Double IF d
specific marker for NK cells, whereas the CD2AP marker is reac
Glyceraldehyde 3-phosphate dehydrogenase gene detection was use
specific protein (NK cell triggering receptor) gene detections indicate
gene transcript detections reveal V(D)J recombination and heavy-ch
CD2AP or NKP46 positivity. Green arrowhead, positive for CD2AP; red
CD2AP and NKP46; blue arrowhead, lymphocytes negative for bothreflect the hypoplastic kidney of SCID zebrafish on gross images
(Figure 3B). Differential cell counting again revealed decreased
lymphocytes fraction in SCID zebrafish. Similar result was also
obtained from the spleen (Table 1).
Further analysis of the cell suspensions was done by flow cytometry
experiment (Figure 4B and Table 2). As revealed in the cell counting,
the SCID zebrafish had a considerably decreased number of the
lymphocytes in peripheral blood, kidney, and spleen compared withdetected by CD2AP marker. The CD2AP-reactive lymphocytes are
suggesting that the cells are either activated T lymphocytes or NK
etected by CD2AP (Cy2) and NKP46 (Cy3) markers. The NKP46 is a
tive to both T lymphocytes and NK cells. (C) RT-PCR analysis.
d as control. Nonspecific cytotoxic cell receptor protein-1 and NK
NK cell. TCR V(D)JC (Vb12-Cb1) and immunoglobulin (IgVH1-Cm)
ain rearrangement. (D) Counted numbers of cells depending on
arrowhead, positive for NKP46; white arrowhead, positive for both
CD2AP and NKP46; yellow arrowhead; red blood cells.
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including erythrocyte and myelomonocyte fractions were similar to
each other. The results suggested that the Prkdc-null SCID zebrafish
underwent an impaired lymphoid development.
Lymphocytes in the SCID Zebrafish Are Natural Killer (NK) Cells
We performed IF analyses with the cell suspensions from peripheral
blood and spleen (Figure 5). Although the CD2AP is used as a marker forthe activated T lymphocytes, NK cells are also known to be reactive to the
CD2AP, whereas NKP46 is widely used as the specific marker for NK
cells. This explains that the CD2AP-reactive lymphocytes can be either
activated T lymphocytes or NK cells, whereas the NKP46-positive cells
are solely to be the NK cells irrespective of the CD2AP expression. As
shown in the Figure 5A, the CD2AP-positive cells were found in the
peripheral blood from both the heterozygote control and the SCID
zebrafish.When the cell suspensions from the peripheral blood and spleen
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lymphocytes from the SCID zebrafish were solely reactive to the CD2AP
marker, suggesting that all of the SCID zebrafish lymphocytes are NK
cells (Figure 5B). On the other hand, the heterozygote control zebrafish
showed positive signals for CD2AP and/or NKP46 markers. The
lymphocyte counting based on the CD2AP or NKP46 positivity was also
summarized in Figure 5D. In the heterozygote control, the positive signals
were detected by either CD2AP or NKP46 (or by the both markers). In
the SCID zebrafish, however, almost all CD2AP-positive cells were also
detected by the NKP46, suggesting that they are NK cells. In conclusion,
the SCID zebrafish contained no activated T lymphocytes, whereas the
control zebrafish contained both activated T lymphocytes and NK cells.
We also performed nested RT-PCR experiments using the mRNAs
extracted from the dissected kidney and spleen to determine if the
hematopoietic tissues included functionalT orB lymphocytes (Figure 5C).
TheRT-PCR results demonstrated that the SCID zebrafish hematopoietic
tissues expressed the mRNAs encoding nonspecific cytotoxic cell receptor
protein-1 and NK cell triggering receptor but lacked the TCR V(D)JC
(Vb12-Cb1) and the immunoglobulin (IgVH1-Cm) gene transcripts,
suggesting that the SCID zebrafish undergoes no V(D)J recombination
and heavy-chain rearrangement. The results indicate that the SCID
zebrafish contains no functional T and B cells.
Xenograft by Intraperitoneal Injection of Cancer Cell Lines
Intraperitoneal injections of the human brain (glioblastoma,
U-87MG), melanoma (CloneM3, SK-MEL28, B16F10), leukemia
(K562), pancreatic (Panc-1, HPAC, Miapaca-2, BxPC-3), and bile
duct (SNU245, SNU478, SNU1196) cancer cell lines were done to
examine the xenograft potential with the SCID zebrafish (Figure 6).
The experiment showed that adult zebrafish well tolerated the
intraperitoneal injection up to 20-μl volume of tumor cell suspension.
We found however that approximately 10% of traumatic death
occurred after the injection. Another adverse event was occurrence of
the “dropsy” phenotype (10% among the injected zebrafish). This
adverse event possibly resulted from the procedure-related infection.
Lentiviral-induced TurboRFP expression of injected cells allowed a
real-time monitoring of the cell growth in the live zebrafish. When
the cancer cell lines were intraperitoneally administrated into the
Prkdc-null SCID zebrafish, the growing tumors were well visualized
by RFP expression (Figure 6, A and B). Besides, repeated observation
every 2 to 3 weeks allowed monitoring the growth of engrafted tumor.
SCID zebrafish, however, were more vulnerable to tricaine anesthesia
that they just tolerated up to 1 minute in tricaine solution, which was
2 minutes in control. Among the various cancer cells, melanoma
(SK-MEL28, CloneM3, and B16F10) and brain tumor cellsFigure 6. Xenograft of tumor cells. Various tumor cells (5 × 104) expre
Hamilton syringe. If not indicated, all H&E and IHC images are 400×.
the growing tumors by visualization of transcutaneous RFP. Tumor e
Bright field (top, asterisk shows amass formed by the growing tumor)
RFP expression. Dissected fat tissue (bottom left) showed scattered R
tail fin are also noted. (C) A mass formed in the liver in SK-MEL28 inje
liver. HLA-ABC positivity of the tumor cells indicates that the mass o
cells are positive for PCNA and Ki-67, suggesting active proliferation. (
the left is a low-power view indicating testis (T), swim bladder (SB), inte
the middle. Merged TurboRFP and H&E image is shown on the right. In
IHC stain. Xenografted tumor cells are positive for HLA-ABC, for pan-c
tumors formed in liver and peritoneal cavity. (F) The xenografted HPAC
muscle (M) and skin. The fibroblast with occasional tumor cells (dott
highly positive to PCNA.(U-87MG) revealed higher rate of microscopic and macroscopic
tumor engraftment compared with the gastrointestinal cancer cells.
When each cell line was injected into 12 zebrafish, overall engrafted
tumors were found in approximately 50% to 70% of the
xenotransplanted SCID zebrafish (Table 3). The engraftment was
never formed in heterozygotes for Prkdc mutation. The most
common site of engraftment was peritoneum followed by liver.
Macroscopic tumor engraftment refers to visible mass on dissection
and was observed in minority of the injected zebrafish, of which the
size measured up to 2 mm.
Tissue section with H&E staining of the zebrafish clearly showed the
growing tumor which was specifically localized and overlapped with the
RFP expression (Figure 6C). The results indicate that the xenografted
tumor has been efficiently formed. IHC experiment further verified that
the xenografted tumors originated from injected cells as they expressed
RFP, HLA-ABC, and pan-cytokeratin (Figure 6, C and D). The
engrafted tumor cells revealed enhanced proliferation as evidenced by
increased PCNA and Ki67 expression.
Interestingly, the tumor mass was often found to be composed of the
massive fibroblast proliferation with the occasional tumor cells (HPAC
cells), reflecting the desmoplastic reaction occurring in pancreatic cancer
(Figure 6F). Taken together, the results indicate that our xenograft with
the intraperitoneal injection of the cancer cell lines into the Prkdc-null
SCID zebrafish has effectively developed tumor generation.
Discussion
SCID mice have widely been used as hosts for human tumor cell
xenograft study [24]. The SCID mice include the gene mutation
which results in the failure of normal development of both T and B
lymphocytes. The PRKDC gene which is responsible for DNA
double-strand break repair system has also been used to develop the
SCID mouse model [5]. As zebrafish has developed into a powerful
tool for immunological study, the zebrafish has also been used as a
xenograft tool for human cancer studies [25–27]. Xenotransplanting
human tumor cell into the zebrafish embryos before the maturation of
adaptive immune function has successively shown in vivo imaging of
early tumor growth and invasion, and tumor angiogenesis [27,28].
Death of the engrafted embryos, however, does not permit a
long-term observation of the tumor behavior. Irradiation approach
has recently been done to develop an immune-depleted adult
zebrafish [29]. Xenotransplantation of cancer stem cells (CSCs) into
the adult zebrafish showed a malignant proliferation of the engrafted
tumor cell, suggesting that the zebrafish could be a good model for
CSC study in vivo. However, recovering immune system of thessing TurboRFP were injected into intraperitoneal space by using a
(A) Gross images. The engraftment allows repeated observation of
ngraftment was never formed in Prkdc+/−. (B) Dissected images.
andmerged RFP (middle) images showing an engrafted tumor with
FP-expressing tumor cells. Metastatic tumor cells (bottom right) at
cted zebrafish. Inset is a low-power view showing mass (M) in the
riginated from injected human melanoma cells. Many of the tumor
D) A discrete mass formed in the Panc-1–injected zebrafish. Inset in
stine (I), andmass (M). Enlarged view of the boxed area is shown in
set in the right is IHC for RFP. Lower column images are findings of
ytokeratin (Pan-CK), and also for PCNA and Ki-67 frequently. (E) The
cells showing the invasive growth, which results in destruction of
ed red circle shown in the middle). The proliferating fibroblasts are
Table 3. Engraftment of Xenotransplated Cancer Cells
Cancer Cells
(Each Cell Line into
12 Zebrafish)
Microscopic
Engraftment
Macroscopic
Engraftment
Engrafted Organs
U-87MG 75% 25% Peritoneum, liver
CloneM3 66.7% 25% Peritoneum, liver
SK-MEL28 75% 33.3% Peritoneum, liver
B16F10 66.7% 16.7% Peritoneum, liver
K562 66.7% 25% Peritoneum, intestine
Panc-1 66.7% 16.7% Peritoneum, liver, pancreas, tail fin
HPAC 58.3% 16.7% Peritoneum, muscle, liver
Miapaca-2 50% 16.7% Peritoneum, liver, ovary
BxPC-3 33.3% 0% Peritoneum, liver
SNU245 41.7% 0% Peritoneum, liver
SNU478 58.3% 16.7% Peritoneum, liver
SNU1196 58.3% 16.7% Peritoneum, liver
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remains as a concern.
Gene mutation strategies for generating immune-deficient zebra-
fish models have been used in zebrafish. The recombination
activation gene 1 (rag1) mutation of zebrafish showed lack of T
and B lymphocytes, suggesting its potential for the use of the mutant
zebrafish as new model system [16]. Later, the first immune-deficient
zebrafish model was created by the Rag2E450fs gene knockout strategy
[17]. The zebrafish permitted robust and long-term engraftment of
multiple tissues and cancer. In our present study, we used TALEN-based
knockout of the Prkdc gene to generate the new SCID zebrafish model
that becomes the counterpart of mouse and rat SCID models. The
TALENs specifically recognized the Prkdc gene sequence and induced
mutation of the gene (Figure 1). As expected, the current SCID zebrafish
clearly showed that the hematologic organs’ development was severely
retarded, causing an impaired lymphoid development (Figure 3). The
SCID zebrafish were virtually devoid of functioning T and B cells with
relatively increased fraction of the monocytes. Other than T or B cells,
lineage analysis of the lymphocytes revealed that almost all of the
lymphocytes in the SCID zebrafish were found to be NK cells. These
findings recapitulate the hematologic phenotypes observed in the SCID
mouse and rat models, which indicate that the Prkdc gene is genetically
preserved between teleost fish and mammals.
The NK cells are versatile, especially in the immune reaction
against tumor cells without restriction by MHC I or II molecules.
The functioning NK cells in the SCID zebrafish may impede the
growth of transplanted tumor cells. Thus, the next step for refining
the SCID zebrafish model may be the sequential knockout of
interleukin-2 receptor γ (duplicated as a and b in zebrafish) to
generate the SCID gamma model which improves the xenograft rate.
Additionally, pigmentation in adult zebrafish can give imaging
limitation for real-time tracing of the tumor cell invasion, intravasa-
tion, extravasation, and angiogenesis in the SCID zebrafish due to the
opacity. This may be overcome by generating a transparent
background obtained from in-crossing of the SCID zebrafish with
Casper (mitfa/roy mutant) zebrafish [30,31].
Several studies have been reported to demonstrate various
laboratory benefits of using the zebrafish as a xenograft model. One
of the reasons is because the zebrafish model provides the unique tool
for visualization of tumor cell behavior. Previously, the zebrafish
xenograft model was introduced to track CSC in tumor invasion and
metastasis [27,28]. The transparent zebrafish enabled tracking of the
xenografted CSC behavior and monitoring the process of tumor cellinvasion in a real-time fashion. Anti-CSC drug evaluation using the
zebrafish xenograft model has also been reported, demonstrating the
suitability of using this animal model for high-throughput screening
of anti-tumor agent [32]. There are also limitations of using the
zebrafish especially when the study undergoes for a specific human
organ cancer. For instance, the zebrafish does not have organs which
are unique to mammals. In a recent study with a zebrafish xenograft
model, however, human breast cancer cell lines were injected and
studied for invasive and metastatic behavior in vivo [28]. This study
showed an application potential of using the zebrafish model for the
mechanistic understanding of the human cancer and also for the
development of pharmacological inhibition for the treatment of the
metastatic cancer. These studies suggest that the zebrafish and their
transparent embryos present a beneficial model system over the
mouse or rat model not only for studying tumor invasion and
metastasis but also for screening anticancer drug.
Another laboratory benefit of using the zebrafish over the mouse or
rat model is availability of the large number of offspring which provides
cost-effectiveness for cancer studies. Maintaining a large number of the
xenografted zebrafish in a small growth chamber allows easy counting to
develop statistical data. For this reason, our study demonstrates
maintenance of the immune-deficient zebrafish lines in the small
growth chamber. Lack of functioning T and B cells, however, rendered
the SCID zebrafish vulnerable to infection. Spontaneous infection,
especially after tail-fin clipping for genotyping, was a cumbersome
problem. Difficulty of maintaining pathogen-free condition (i.e.,
Specific pathogen-free (SPF) environment in mouse facility) in the
aquaria system can also be an issue for the expansion of
immune-deficient zebrafish models. We overcame this difficulty by
maintaining the SCID zebrafish in the separate system with meticulous
care of breeding water and weekly addition of antibiotics, decreasing the
infection rate to below 10%. This will minimize the burden of expense
which occurs during maintenance of the immune-deficient mouse
model in Specific pathogen-free (SPF) environment.
Xenotransplantation experiment was done by utilizing various
cancer cells including melanoma and brain, pancreas, and bile duct
cancer cells (Figure 6). Many of the previous studies have used
leukemia or melanoma cells which are rapid growing and highly
tumorigenic because of a higher rate of genetic aberration. Current
model also revealed higher engraftment rates by melanoma and brain
cancer cells than by gastrointestinal cancer cells. Pancreatic and biliary
tumors are notorious for evading early diagnosis, of which the
treatment is largely dependent on systemic chemotherapy. Although
xenograft rates were not very high in the current model, successful
engraftment of these tumor cells can provide a valuable platform for
cancer research and personalized treatment.
To summarize, generation of the homozygote Prkdc-null mutation
in the zebrafish allowed the immune-deficient background lacking
the functional T and B cells (Figure 5), and this provided an efficient
environment for intraperitoneal injection of the human cancer cell
lines to grow into tumor (Figure 6). Our study presents a complete
knockout of Prkdc gene of zebrafish and demonstrates the suitability
of using this gene mutation to develop a new xenograft animal model
for cancer research. The successful xenotransplantation of the
gastrointestinal tumors shown in this study may expand the
application of the immunocompromised zebrafish strain to drug
sensitivity test. The SCID zebrafish model will provide a new
platform of tumor xenograft study for tumor biology and
immunology as well as for anticancer drug development.
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